Logo image of BX

BLACKSTONE INC (BX) Stock Fundamental Analysis

USA - NYSE:BX - US09260D1072 - Common Stock

178.08 USD
-6.83 (-3.69%)
Last: 9/24/2025, 8:04:01 PM
178.49 USD
+0.41 (+0.23%)
After Hours: 9/24/2025, 8:04:01 PM
Fundamental Rating

5

BX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 236 industry peers in the Capital Markets industry. While BX belongs to the best of the industry regarding profitability, there are concerns on its financial health. BX is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

BX had positive earnings in the past year.
In the past year BX had a positive cash flow from operations.
Each year in the past 5 years BX has been profitable.
BX had a positive operating cash flow in each of the past 5 years.
BX Yearly Net Income VS EBIT VS OCF VS FCFBX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

1.2 Ratios

BX has a Return On Assets of 6.31%. This is in the better half of the industry: BX outperforms 77.97% of its industry peers.
The Return On Equity of BX (34.29%) is better than 96.61% of its industry peers.
With an excellent Return On Invested Capital value of 17.66%, BX belongs to the best of the industry, outperforming 92.80% of the companies in the same industry.
BX had an Average Return On Invested Capital over the past 3 years of 12.81%. This is significantly above the industry average of 7.59%.
The last Return On Invested Capital (17.66%) for BX is above the 3 year average (12.81%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.31%
ROE 34.29%
ROIC 17.66%
ROA(3y)4.65%
ROA(5y)6.43%
ROE(3y)25.68%
ROE(5y)30.98%
ROIC(3y)12.81%
ROIC(5y)17.48%
BX Yearly ROA, ROE, ROICBX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

The Profit Margin of BX (20.83%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of BX has declined.
BX has a Operating Margin of 50.95%. This is amongst the best in the industry. BX outperforms 85.59% of its industry peers.
BX's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 50.95%
PM (TTM) 20.83%
GM N/A
OM growth 3Y-4.19%
OM growth 5Y1.25%
PM growth 3Y-6.82%
PM growth 5Y-5.56%
GM growth 3YN/A
GM growth 5YN/A
BX Yearly Profit, Operating, Gross MarginsBX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

BX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BX has more shares outstanding
BX has a better debt/assets ratio than last year.
BX Yearly Shares OutstandingBX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BX Yearly Total Debt VS Total AssetsBX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 4.28 indicates that BX is not in any danger for bankruptcy at the moment.
BX has a better Altman-Z score (4.28) than 82.63% of its industry peers.
BX has a debt to FCF ratio of 3.66. This is a good value and a sign of high solvency as BX would need 3.66 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.66, BX is in the better half of the industry, outperforming 75.85% of the companies in the same industry.
A Debt/Equity ratio of 1.44 is on the high side and indicates that BX has dependencies on debt financing.
The Debt to Equity ratio of BX (1.44) is worse than 69.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF 3.66
Altman-Z 4.28
ROIC/WACCN/A
WACCN/A
BX Yearly LT Debt VS Equity VS FCFBX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

BX has a Current Ratio of 0.70. This is a bad value and indicates that BX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of BX (0.70) is worse than 66.53% of its industry peers.
BX has a Quick Ratio of 0.70. This is a bad value and indicates that BX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of BX (0.70) is worse than 66.10% of its industry peers.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.7
BX Yearly Current Assets VS Current LiabilitesBX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.31% over the past year.
BX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.97% yearly.
The Revenue has grown by 33.33% in the past year. This is a very strong growth!
Measured over the past years, BX shows a quite strong growth in Revenue. The Revenue has been growing by 12.51% on average per year.
EPS 1Y (TTM)25.31%
EPS 3Y-0.92%
EPS 5Y14.97%
EPS Q2Q%26.04%
Revenue 1Y (TTM)33.33%
Revenue growth 3Y-16.32%
Revenue growth 5Y12.51%
Sales Q2Q%22.18%

3.2 Future

BX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.53% yearly.
Based on estimates for the next years, BX will show a quite strong growth in Revenue. The Revenue will grow by 15.92% on average per year.
EPS Next Y12.04%
EPS Next 2Y20.42%
EPS Next 3Y21.84%
EPS Next 5Y12.53%
Revenue Next Year9.27%
Revenue Next 2Y18%
Revenue Next 3Y19.89%
Revenue Next 5Y15.92%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BX Yearly Revenue VS EstimatesBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
BX Yearly EPS VS EstimatesBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 35.62, BX can be considered very expensive at the moment.
Based on the Price/Earnings ratio, BX is valued a bit more expensive than 74.58% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.29, BX is valued a bit more expensive.
The Price/Forward Earnings ratio is 26.47, which means the current valuation is very expensive for BX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BX indicates a slightly more expensive valuation: BX is more expensive than 68.64% of the companies listed in the same industry.
BX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.80, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 35.62
Fwd PE 26.47
BX Price Earnings VS Forward Price EarningsBX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BX is cheaper than 64.41% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as BX.
Industry RankSector Rank
P/FCF 64.31
EV/EBITDA 32.46
BX Per share dataBX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of BX may justify a higher PE ratio.
BX's earnings are expected to grow with 21.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.96
PEG (5Y)2.38
EPS Next 2Y20.42%
EPS Next 3Y21.84%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.26%, BX has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 8.21, BX has a dividend in line with its industry peers.
BX's Dividend Yield is comparable with the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 2.26%

5.2 History

On average, the dividend of BX grows each year by 11.16%, which is quite nice.
BX has paid a dividend for at least 10 years, which is a reliable track record.
BX has decreased its dividend recently.
Dividend Growth(5Y)11.16%
Div Incr Years1
Div Non Decr Years1
BX Yearly Dividends per shareBX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

BX pays out 182.75% of its income as dividend. This is not a sustainable payout ratio.
The dividend of BX is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP182.75%
EPS Next 2Y20.42%
EPS Next 3Y21.84%
BX Yearly Income VS Free CF VS DividendBX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
BX Dividend Payout.BX Dividend Payout, showing the Payout Ratio.BX Dividend Payout.PayoutRetained Earnings

BLACKSTONE INC

NYSE:BX (9/24/2025, 8:04:01 PM)

After market: 178.49 +0.41 (+0.23%)

178.08

-6.83 (-3.69%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)07-24 2025-07-24/bmo
Earnings (Next)10-16 2025-10-16/amc
Inst Owners70.37%
Inst Owner Change12.98%
Ins Owners0.8%
Ins Owner Change5.08%
Market Cap210.97B
Analysts76.77
Price Target186.45 (4.7%)
Short Float %1.53%
Short Ratio2.98
Dividend
Industry RankSector Rank
Dividend Yield 2.26%
Yearly Dividend6.1
Dividend Growth(5Y)11.16%
DP182.75%
Div Incr Years1
Div Non Decr Years1
Ex-Date08-04 2025-08-04 (1.03)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.84%
Min EPS beat(2)0.65%
Max EPS beat(2)7.03%
EPS beat(4)4
Avg EPS beat(4)6.66%
Min EPS beat(4)0.65%
Max EPS beat(4)12.43%
EPS beat(8)5
Avg EPS beat(8)2.96%
EPS beat(12)7
Avg EPS beat(12)2.84%
EPS beat(16)11
Avg EPS beat(16)8.35%
Revenue beat(2)1
Avg Revenue beat(2)3.38%
Min Revenue beat(2)-0.22%
Max Revenue beat(2)6.98%
Revenue beat(4)2
Avg Revenue beat(4)2.44%
Min Revenue beat(4)-1.86%
Max Revenue beat(4)6.98%
Revenue beat(8)2
Avg Revenue beat(8)-1.46%
Revenue beat(12)2
Avg Revenue beat(12)-13.7%
Revenue beat(16)5
Avg Revenue beat(16)7.59%
PT rev (1m)1.01%
PT rev (3m)20.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.51%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)4.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.79%
Valuation
Industry RankSector Rank
PE 35.62
Fwd PE 26.47
P/S 15.35
P/FCF 64.31
P/OCF 62.4
P/B 25.26
P/tB 33.41
EV/EBITDA 32.46
EPS(TTM)5
EY2.81%
EPS(NY)6.73
Fwd EY3.78%
FCF(TTM)2.77
FCFY1.55%
OCF(TTM)2.85
OCFY1.6%
SpS11.6
BVpS7.05
TBVpS5.33
PEG (NY)2.96
PEG (5Y)2.38
Profitability
Industry RankSector Rank
ROA 6.31%
ROE 34.29%
ROCE 21.17%
ROIC 17.66%
ROICexc 19.13%
ROICexgc 20.63%
OM 50.95%
PM (TTM) 20.83%
GM N/A
FCFM 23.86%
ROA(3y)4.65%
ROA(5y)6.43%
ROE(3y)25.68%
ROE(5y)30.98%
ROIC(3y)12.81%
ROIC(5y)17.48%
ROICexc(3y)14.24%
ROICexc(5y)19.2%
ROICexgc(3y)15.53%
ROICexgc(5y)21.12%
ROCE(3y)15.37%
ROCE(5y)21.01%
ROICexcg growth 3Y-21.19%
ROICexcg growth 5Y9.44%
ROICexc growth 3Y-21.05%
ROICexc growth 5Y9.86%
OM growth 3Y-4.19%
OM growth 5Y1.25%
PM growth 3Y-6.82%
PM growth 5Y-5.56%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF 3.66
Debt/EBITDA 1.71
Cap/Depr 280.1%
Cap/Sales 0.73%
Interest Coverage 14.47
Cash Conversion 48.02%
Profit Quality 114.54%
Current Ratio 0.7
Quick Ratio 0.7
Altman-Z 4.28
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)360.42%
Cap/Depr(5y)264.86%
Cap/Sales(3y)2.01%
Cap/Sales(5y)1.63%
Profit Quality(3y)249.28%
Profit Quality(5y)197.86%
High Growth Momentum
Growth
EPS 1Y (TTM)25.31%
EPS 3Y-0.92%
EPS 5Y14.97%
EPS Q2Q%26.04%
EPS Next Y12.04%
EPS Next 2Y20.42%
EPS Next 3Y21.84%
EPS Next 5Y12.53%
Revenue 1Y (TTM)33.33%
Revenue growth 3Y-16.32%
Revenue growth 5Y12.51%
Sales Q2Q%22.18%
Revenue Next Year9.27%
Revenue Next 2Y18%
Revenue Next 3Y19.89%
Revenue Next 5Y15.92%
EBIT growth 1Y39.89%
EBIT growth 3Y-19.82%
EBIT growth 5Y13.91%
EBIT Next Year5.24%
EBIT Next 3Y19.12%
EBIT Next 5Y6.22%
FCF growth 1Y-6.6%
FCF growth 3Y-4.46%
FCF growth 5Y12.44%
OCF growth 1Y-10.47%
OCF growth 3Y-4.41%
OCF growth 5Y12.14%